Silence Therapeutics plc (SLN) on GreekSoup https://greeksoup.ai/stocks/us/sln/ Every dated entry in the public record on Silence Therapeutics plc: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 Silence Therapeutics plc filed DEFA14A: defa14ahttps://greeksoup.ai/stocks/us/sln/filings/us:SLN:filing:2026-10-19:4f4992aedfMon, 19 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Silence Therapeutics plc filed DEFA14A: defa14ahttps://greeksoup.ai/stocks/us/sln/filings/us:SLN:filing:2026-10-19:60ee935258Mon, 19 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Silence Therapeutics plc filed 8-K: material agreement, regulation fd disclosurehttps://greeksoup.ai/stocks/us/sln/filings/us:SLN:filing:2026-10-19:6ef375f922Mon, 19 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Silence Therapeutics plc: short interest 2,927,366 shares at the 15 October 2026 settlement, 2.30 days to coverhttps://greeksoup.ai/stocks/us/sln/short-interest/us:SLN:short-interest:2026-10-15:2351266621Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Silence Therapeutics plc: Schedule 13G/A filed by Tetragon Financial Group Limited, 5.3% of the classhttps://greeksoup.ai/stocks/us/sln/holders/us:SLN:schedule-13:2026-10-13:084b7b7413Tue, 13 Oct 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Silence Therapeutics plc: Schedule 13G filed by Tetragon Financial Group Limited, 5.2% of the classhttps://greeksoup.ai/stocks/us/sln/holders/us:SLN:schedule-13:2026-10-13:4e26be190bTue, 13 Oct 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Silence Therapeutics plc: short interest 2,538,328 shares at the 30 September 2026 settlement, 3.07 days to coverhttps://greeksoup.ai/stocks/us/sln/short-interest/us:SLN:short-interest:2026-09-30:79c58931e7Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Silence Therapeutics plc: short interest 2,178,055 shares at the 15 September 2026 settlement, 2.53 days to coverhttps://greeksoup.ai/stocks/us/sln/short-interest/us:SLN:short-interest:2026-09-15:ef24977114Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Silence Therapeutics plc: short interest 2,435,831 shares at the 31 August 2026 settlement, 3.50 days to coverhttps://greeksoup.ai/stocks/us/sln/short-interest/us:SLN:short-interest:2026-08-31:0ac8eab860Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Silence Therapeutics plc: short interest 2,432,830 shares at the 14 August 2026 settlement, 1.00 days to coverhttps://greeksoup.ai/stocks/us/sln/short-interest/us:SLN:short-interest:2026-08-14:b00be81440Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Silence Therapeutics plc: Schedule 13G/A filed by Invus Public Equities, L.P., 7.0% of the classhttps://greeksoup.ai/stocks/us/sln/holders/us:SLN:schedule-13:2026-08-13:e44ecc118eThu, 13 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Silence Therapeutics plc: Schedule 13D/A filed by Richard Griffiths, 8.0% of the classhttps://greeksoup.ai/stocks/us/sln/holders/us:SLN:schedule-13:2026-08-13:c8b461a5c9Thu, 13 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Silence Therapeutics plc filed 8-K: material agreement, other eventshttps://greeksoup.ai/stocks/us/sln/filings/us:SLN:filing:2026-08-12:a19f888b75Wed, 12 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Silence Therapeutics plc Q2 FY2026 results: revenue $0, net income -$12 millionhttps://greeksoup.ai/stocks/us/sln/results/fy2026-q2/us:SLN:result:2026-08-10:4df4ed1ef9Mon, 10 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Silence Therapeutics plc filed 8-K: regulation fd disclosure, other eventshttps://greeksoup.ai/stocks/us/sln/filings/us:SLN:filing:2026-08-10:e33728ca63Mon, 10 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Silence Therapeutics plc filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/sln/filings/us:SLN:filing:2026-08-10:784da1c772Mon, 10 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Silence Therapeutics plc filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/sln/filings/us:SLN:filing:2026-08-10:ef64c2ea58Mon, 10 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Silence Therapeutics plc: short interest 1,837,238 shares at the 31 July 2026 settlement, 3.28 days to coverhttps://greeksoup.ai/stocks/us/sln/short-interest/us:SLN:short-interest:2026-07-31:0885db8ff8Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>